-
Erastin Workflow for Ferroptosis Research
2026-09-24
Use Erastin to probe cystine-dependent redox vulnerability and ferroptotic death in cancer models, with a practical workflow for dosing, controls, and assay interpretation. A recent melanocyte study offers a complementary framework for connecting oxidative injury with inflammatory signaling—while underscoring why the inducer and cell model must match the question.
-
mCherry mRNA for LNP Workflow Validation
2026-09-24
Use red fluorescent protein mRNA to compare delivery conditions and verify reporter expression before advancing to more complex cell-engineering experiments. This practical guide pairs EZ Cap™ mCherry mRNA with a careful interpretation of LNP research in dystrophic epidermolysis bullosa fibroblasts—without treating a fluorescent signal as proof of gene correction.
-
Cy3-UTP for RNA Spatial-Organization Studies
2026-09-23
Cy3-UTP supports fluorescent RNA experiments, but interpreting nuclear organization requires more than seeing a signal. Learn how to use Cy3-modified uridine triphosphate to investigate RNA interactions while distinguishing labeled-RNA tracking from endogenous gene positioning.
-
Rex NADH/NAD+ Biosensor for Bacterial Redox
2026-09-23
Liu, Landick, and Raman developed a genetically encoded, Rex-regulated ratiometric biosensor for measuring bacterial NADH/NAD+ redox state. The platform revealed respiratory-chain and carbon-source effects on redox balance and enabled enrichment of rare high-NADH mutants, providing a practical framework for noninvasive metabolic screening.
-
Kidney-Targeted mRNA Nanoparticles: Study Insights
2026-09-22
This 2024 Pace University dissertation examines how excipients can increase mRNA loading in polymeric mesoscale nanoparticles while preserving particle size, tolerability, uptake, and expression. Its main contribution is a multivariable formulation framework for evaluating renal-targeted mRNA carriers rather than treating encapsulation efficiency as the sole performance endpoint.
-
EZ Cap™ EGFP mRNA: Practical Workflow Guide
2026-09-22
EZ Cap™ EGFP mRNA (SKU R1002) is a Cap 1 EGFP reporter mRNA input for comparing delivery and transient expression in research systems. It is appropriate for controlled assay development, but the dossier does not define a universal dose, cell type, delivery reagent, readout window, or expected performance outcome.
-
Indomethacin (A8449): Practical Lab Protocols
2026-09-21
Indomethacin (SKU A8449) provides a controllable way to examine cyclooxygenase inhibition, inflammation-associated readouts, PPAR-linked transcriptional responses, and selected membrane effects. This guide covers solvent handling, assay controls, and quality checks while emphasizing that product-dossier potency values should not be treated as cellular dosing instructions or as evidence for every experimental model.
-
Carboplatin: DNA Synthesis Inhibitor for Cancer Research
2026-09-21
Carboplatin is a platinum-based DNA synthesis inhibitor used in preclinical oncology research to study DNA damage, tumor-cell proliferation, and chemoresistance. Product benchmarks cover ovarian and lung cancer models, while recent TNBC evidence connects carboplatin resistance with the IGF2BP3–FZD1/7 axis.
-
EdU Flow Cytometry Assay Kits (Cy5): S-Phase Guide
2026-09-20
EdU Flow Cytometry Assay Kits (Cy5) quantify DNA synthesis by labeling replicating DNA and detecting it through copper-catalyzed azide-alkyne cycloaddition (CuAAC). The K1078 workflow supports denaturation-free flow cytometry cell proliferation analysis and can be integrated with cell-cycle or antibody measurements.
-
Nav1.5 Ser571 Links Late INa to Cardiac Aging
2026-09-19
The 2024 reference study uses bidirectional Nav1.5 Ser571 mouse models to connect increased late sodium current with delayed ventricular repolarization, impaired diastolic filling, and slower cardiomyocyte relaxation during aging. Its genetic and pharmacological design supports late-current regulation as a mechanistic target for cardiac aging research while highlighting the need to distinguish electrical recovery from broader conduction effects.
-
Firefly Luciferase mRNA: A Better Assay Control
2026-09-18
EZ Cap™ Firefly Luciferase mRNA (m1Ψ) turns bioluminescence into a structured way to evaluate delivery, translation, and cell state. This guide connects Cap1 and m1Ψ design with lessons from next-generation mRNA cell therapy while defining practical controls and assay limitations.
-
Nonivamide (Capsaicin Analog): TRPV1 Strategy
2026-09-18
Nonivamide links selective TRPV1 activation with apoptosis-oriented cancer research and sensory neuroimmune biology. This translational framework explains how to validate mechanism, manage experimental variables, and distinguish a versatile research tool from a clinically ready intervention.
-
Carbapenemase Transmission in CREC: Guangdong Study
2026-09-17
Chen and colleagues combined carbapenemase-gene localization, antimicrobial susceptibility testing, conjugation, mobile-element analysis, and ERIC-PCR typing to examine carbapenem-resistant Enterobacter cloacae from eight teaching hospitals in Guangdong. The findings emphasize plasmid-associated blaNDM-1, frequent multidrug resistance, and the need to distinguish clonal relatedness from horizontal gene transfer in hospital surveillance.
-
EZ Cap EGFP mRNA 5-moUTP: Applied Workflows
2026-09-17
Use EZ Cap EGFP mRNA 5-moUTP as a fluorescent benchmark for delivery, translation, viability, and tissue-localization studies. Its Cap1 structure, 5-moU nucleotides, and optimized poly(A) tail make it particularly useful for separating nanoparticle uptake from productive protein expression.
-
Cy3 TSA Fluorescence System Kit for Cancer Imaging
2026-09-16
The Cy3 TSA Fluorescence System Kit converts modest HRP activity into a localized, high-density fluorescent signal for difficult IHC, ICC, and ISH targets. This practical guide connects TSA workflow design with SIX1-driven lipogenesis research, showing how to improve detection of low-abundance biomolecules without sacrificing spatial context.